IBNYX
Price
$25.14
Change
+$0.09 (+0.36%)
Updated
Jul 25 closing price
Net Assets
1.6B
RLEFX
Price
$37.17
Change
+$0.07 (+0.19%)
Updated
Jul 25 closing price
Net Assets
254.37B
Interact to see
Advertisement

IBNYX vs RLEFX

Header iconIBNYX vs RLEFX Comparison
Open Charts IBNYX vs RLEFXBanner chart's image
Macquarie Balanced Fund
Price$25.14
Change+$0.09 (+0.36%)
VolumeN/A
Net Assets1.6B
American Funds American Balanced R5E
Price$37.17
Change+$0.07 (+0.19%)
VolumeN/A
Net Assets254.37B
IBNYX vs RLEFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IBNYX vs. RLEFX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBNYX is a Buy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 254B vs. IBNYX (1.6B). RLEFX pays higher dividends than IBNYX: RLEFX (2.01) vs IBNYX (1.01). IBNYX was incepted earlier than RLEFX: IBNYX (22 years) vs RLEFX (10 years). IBNYX (1.08) is less costly to investors than RLEFX (0.39). IBNYX is a more actively managed with annual turnover of: 76.00 vs. RLEFX (44.00). IBNYX has a lower initial minimum investment than RLEFX: IBNYX (0) vs RLEFX (250). IBNYX annual gain was more profitable for investors over the last year : 13.37 vs. RLEFX (10.46). RLEFX return over 5 years is better than : 40.77 vs. IBNYX (9.15).
IBNYXRLEFXIBNYX / RLEFX
Total Expense Ratio1.060.39272%
Annual Report Gross Expense Ratio1.080.39277%
Fund Existence22 years10 years-
Gain YTD7.4629.13382%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.6B254B1%
Annual Yield % from dividends1.012.0150%
Returns for 1 year13.3710.46128%
Returns for 3 years13.2635.4237%
Returns for 5 years9.1540.7722%
Returns for 10 years8.26N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVRA2.580.03
+1.18%
Savara
WEX175.621.52
+0.87%
WEX
CGON26.10-0.04
-0.15%
CG Oncology
LFVN13.71-0.27
-1.93%
Lifevantage Corp
ISPC1.07-0.03
-2.79%
iSpecimen Inc